Oshi Health continued to advance its virtual gastrointestinal care strategy this week, emphasizing integrated specialty benefits, new provider partnerships, and data-backed outcomes for employers and payers. The company positioned its clinician-led GI model as a solution to access gaps and rising costs in digestive and related chronic conditions.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
At the SALGBA 2026 National Conference, Oshi Health highlighted a panel featuring its lead GI provider focused on integrating diabetes, musculoskeletal, and digestive care within employer-sponsored benefits. The company underscored how virtual and digital tools can coordinate care, reduce surgeries and ER visits, and improve adherence to therapies, including GLP-1 medications.
Oshi Health also expanded its presence in the gastroenterology market through a strategic partnership with One GI, a large network of independent GI practices, anchored by its Access+ program. The collaboration allows One GI to use GI-trained Oshi advanced practice providers as integrated virtual staff, increasing visit capacity without adding local headcount or physical space.
The One GI arrangement is designed to offer same-day, evening, and weekend virtual appointments under One GI physician oversight, with front-desk teams booking Oshi visits as if they were in-house. This model aims to cut wait times, reduce emergency department leakage, and support more comprehensive management of complex GI conditions via embedded dietitians and behavioral health providers.
During IBS Awareness Month, Oshi Health used educational campaigns to encourage patients to openly discuss symptoms and track patterns using tools like the Bristol Stool Chart. The company framed stigma reduction and patient communication as levers to improve engagement, drive earlier diagnosis, and widen the funnel into its virtual GI programs.
Oshi’s 2025 Impact Report showcased multi-year outcomes, including 97% of patients achieving symptom control, a 90% reduction in moderate-to-severe symptoms, and 97% patient satisfaction. The company also reported 68% fewer GI-related ER visits, 95% colorectal cancer screening compliance, and an 8.17 return on investment with more than $6,000 in annual savings per member.
Management is using these results in discussions with health plans, self-insured employers, and benefits consultants, aligning Oshi with value-based care and vendor accountability themes. CEO Sam Holliday is slated to present the company’s performance data at the Business Group on Health 2026 Annual Conference, potentially supporting broader commercial adoption and revenue visibility.
Overall, the week highlighted Oshi Health’s efforts to combine capacity-expanding partnerships, integrated benefit strategies, and outcomes-driven messaging to strengthen its position in the virtual GI and chronic care market.